Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review

Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review

Abstract Background In Europe, treatment of metastatic colorectal cancer (mCRC) with panitumumab requires prior confirmation of RAS wild-type mutation status. Two studies – a physician survey and a medical records review (MRR) – were conducted to evaluate the use of panitumumab and awareness among p...

Full description

Bibliographic Details
Main Authors: J. Han van Krieken, George Kafatos, James Bennett, Laurent Mineur, Jiří Tomášek, Etienne Rouleau, Pavel Fabian, Giovanna De Maglio, Pilar García-Alfonso, Giuseppe Aprile, Parijan Parkar, Gerald Downey, Gaston Demonty, Jörg Trojan
Format: Article
Language:English
Published: BMC 2017-11-01
Series:BMC Cancer
Subjects:
Panitumumab
Metastatic colorectal cancer
mCRC
RAS
Physician survey
Medical records review
Online Access:http://link.springer.com/article/10.1186/s12885-017-3740-4

Internet

http://link.springer.com/article/10.1186/s12885-017-3740-4

Similar Items